The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh, UK.
School of Chemistry, University of Edinburgh, Edinburgh, UK.
J Bone Miner Res. 2020 Feb;35(2):357-367. doi: 10.1002/jbmr.3888. Epub 2019 Oct 29.
Arterial calcification is an important hallmark of cardiovascular disease and shares many similarities with skeletal mineralization. The bone-specific protein osteocalcin (OCN) is an established marker of vascular smooth muscle cell (VSMC) osteochondrogenic transdifferentiation and a known regulator of glucose metabolism. However, the role of OCN in controlling arterial calcification is unclear. We hypothesized that OCN regulates calcification in VSMCs and sought to identify the underpinning signaling pathways. Immunohistochemistry revealed OCN co-localization with VSMC calcification in human calcified carotid artery plaques. Additionally, 3 mM phosphate treatment stimulated OCN mRNA expression in cultured VSMCs (1.72-fold, p < 0.001). Phosphate-induced calcification was blunted in VSMCs derived from OCN null mice (Ocn ) compared with cells derived from wild-type (WT) mice (0.37-fold, p < 0.001). Ocn VSMCs showed reduced mRNA expression of the osteogenic marker Runx2 (0.51-fold, p < 0.01) and the sodium-dependent phosphate transporter, PiT1 (0.70-fold, p < 0.001), with an increase in the calcification inhibitor Mgp (1.42-fold, p < 0.05) compared with WT. Ocn VSMCs also showed reduced mRNA expression of Axin2 (0.13-fold, p < 0.001) and Cyclin D (0.71 fold, p < 0.01), markers of Wnt signaling. CHIR99021 (GSK3β inhibitor) treatment increased calcium deposition in WT and Ocn VSMCs (1 μM, p < 0.001). Ocn VSMCs, however, calcified less than WT cells (1 μM; 0.27-fold, p < 0.001). Ocn VSMCs showed reduced mRNA expression of Glut1 (0.78-fold, p < 0.001), Hex1 (0.77-fold, p < 0.01), and Pdk4 (0.47-fold, p < 0.001). This was accompanied by reduced glucose uptake (0.38-fold, p < 0.05). Subsequent mitochondrial function assessment revealed increased ATP-linked respiration (1.29-fold, p < 0.05), spare respiratory capacity (1.59-fold, p < 0.01), and maximal respiration (1.52-fold, p < 0.001) in Ocn versus WT VSMCs. Together these data suggest that OCN plays a crucial role in arterial calcification mediated by Wnt/β-catenin signaling through reduced maximal respiration. Mitochondrial dynamics may therefore represent a novel therapeutic target for clinical intervention. © 2019 American Society for Bone and Mineral Research.
动脉钙化是心血管疾病的一个重要标志,它与骨骼矿化有许多相似之处。骨特异性蛋白骨钙素(OCN)是血管平滑肌细胞(VSMC)成骨软骨转化的一个既定标志物,也是众所周知的葡萄糖代谢调节剂。然而,OCN 调控动脉钙化的确切机制尚不清楚。我们假设 OCN 调控 VSMC 的钙化,并试图确定其潜在的信号通路。免疫组织化学显示 OCN 与人钙化颈动脉斑块中的 VSMC 钙化共定位。此外,3mmol/L 磷酸盐处理可刺激培养的 VSMC 中 OCN mRNA 表达(1.72 倍,p<0.001)。与野生型(WT)小鼠来源的细胞相比,OCN 敲除(Ocn-/-)小鼠来源的 VSMC 中的磷酸盐诱导的钙化减少(0.37 倍,p<0.001)。Ocn-/-VSMC 的成骨标志物 Runx2 的 mRNA 表达减少(0.51 倍,p<0.01),钠依赖性磷酸盐转运蛋白 PiT1 的 mRNA 表达减少(0.70 倍,p<0.001),钙化抑制剂 Mgp 的表达增加(1.42 倍,p<0.05),而 WT 细胞则不然。Ocn-/-VSMC 中 Axin2 和 Cyclin D 的 mRNA 表达也减少(Axin2,0.13 倍,p<0.001;Cyclin D,0.71 倍,p<0.01),这是 Wnt 信号的标志物。CHIR99021(GSK3β 抑制剂)处理可增加 WT 和 Ocn-/-VSMC 的钙沉积(1μM,p<0.001)。然而,与 WT 细胞相比,Ocn-/-VSMC 的钙化减少(1μM,0.27 倍,p<0.001)。Ocn-/-VSMC 的葡萄糖转运蛋白 Glut1(0.78 倍,p<0.001)、Hex1(0.77 倍,p<0.01)和 Pdk4(0.47 倍,p<0.001)的 mRNA 表达减少。这伴随着葡萄糖摄取减少(0.38 倍,p<0.05)。随后的线粒体功能评估显示,与 WT VSMC 相比,Ocn-/-VSMC 的 ATP 连接呼吸(1.29 倍,p<0.05)、备用呼吸能力(1.59 倍,p<0.01)和最大呼吸(1.52 倍,p<0.001)增加。这些数据表明,OCN 通过降低最大呼吸,在 Wnt/β-连环蛋白信号通路介导的动脉钙化中发挥关键作用。因此,线粒体动力学可能是临床干预的一个新的治疗靶点。